IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS
1986: Sandoz took a 50% stake in Gema/Liessa SA (Spain), an an ti bi ot ics raw ma te rial pro ducer, to form
a joint ven ture with Lonza (Swit zer land). Sandoz bought a ma jor ity stake in LPB Istituto Farmaceutico
(It aly). Sandoz con sol i dated its US OTC busi ness, merg ing Dorsey Labs with Ex-Lax Phar ma ceu ti cal Co.
Ciba ac quired Nes tle’s (Swit zer land) Eu ro pean and US con tact lens busi nesses. Ciba pur chased 50% of
Dispersa AG (Swit zer land) and Dispersa-Baeschlin GmbH (Ger many), phar ma ceu ti cal pro duc ers, from
Galenica (Switzerland).
1985: Ciba ac quired Amer i can Op ti cal Corp’s (USA) con tact lens and lenscare busi ness.
1983: Sandoz ac quired sweet en ers firm, F Ahlgrens Tekniska Fabrik (Swe den). Ciba ac quired Titmus
Eurocon (Ger many), a con tact lens and lenscare prod ucts man u fac turer.
1982: Sandoz bought Wasa (Swe den), a pro ducer of crispbread.
1981: Sandoz ac quired the OTC med i cines unit of Culbro Corp and Ex-Lax Phar ma ceu ti cal Co Inc (USA);
and Vi king Brews Ltd, North Shields, UK.
1980: Ciba ac quired the Mett ler com pany.
• Year: 1970s
1979: Ciba bought SJ Tutag & Co (USA), a generics man u fac turer, re nam ing it Geneva Pharmaceuticals
Inc.
1978: Sandoz ac quired Leofarin Group (Swit zer land).
1976: Sandoz pur chased 99% of Northrup, King & Co (USA) and bought Chi cago Di etet ics Co (USA).
1972: Sandoz bought Delmark (USA), a nu tri tional firm and STIA (Swit zer land).
1970: Ciba, founded in 1884, and JR Geigy Co, founded in 1758, merged to form Ciba-Geigy Lim ited.
• Year: 1960s
1967: Sandoz ac quired Wan der (Swit zer land), a nu tri tional prod ucts firm.
1963: Sandoz bought Biochemie GmbH (Aus tria), an an ti bi otic man u fac turer.
Other Major Events
• Year: 2009
Feb ru ary: Novartis launched a ma jor bond mar ket trans ac tion, is su ing a two-tranche bond with a to tal
size of $5 bil lion that has been reg is tered in the US. The trans ac tion con sists of the fol low ing tranch es: $2
bil lion of a 5-year bond with a cou pon of 4.125% and $3 bil lion of a 10-year bond with a coupon of
5.125%.
• Year: 2008
Oc to ber: Novartis an nounced plans to buy the pul mo nary drug de liv ery unit of Nektar (USA). It will ac -
quire spe cific pul mo nary de liv ery as sets, tech nol ogy, and in tel lec tual prop erty from Nektar for $115 mil -
lion in cash. Cer tain dry pow der and liq uid pul mo nary for mu la tion and man u fac tur ing as sets (in clud ing
cap i tal equip ment and man u fac tur ing cap i tal lease ob li ga tions) will be ac quired by Novartis. Novartis will
© 2009 IMS Health In cor po rated or its af fil i ates Page 142